Patient
|
Number of env clones
|
Subtype
|
HIV-1 tropisma
|
π (%)
|
HSN
|
Proportion of unique sequences (%)
|
---|
PEC02
|
14
|
B
|
100% R5
|
4.4
|
0.72
|
57
|
PEC52
|
16
|
B
|
100 X4
|
0.1
|
0.36
|
18
|
PEC30
|
11
|
B
|
55% R5
|
45% X4
|
2.9
|
0.88
|
81
|
PEC35
|
19
|
F1
|
100% R5
|
0.1
|
0.23
|
21
|
PEC38
|
15
|
A
|
100% R5
|
3.9
|
0.80
|
60
|
PEC39a
|
14
|
B
|
100% R5
|
4.2
|
0.97
|
93
|
EEC09
|
12
|
B
|
100% R5
|
0.5
|
–
|
45
|
21
|
F1
|
100% R5
|
0.2
|
0.59
|
38
|
EEC11a
|
13
|
B
|
100% R5
|
0.2
|
0.57
|
38
|
EEC42
|
16
|
B
|
100% R5
|
1.9
|
1.00
|
100
|
EEC17
|
10
|
B
|
100% R5
|
4.6
|
0.94
|
90
|
EEC18
|
20
|
B
|
95% R5
|
5% X4
|
2.7
|
0.87
|
75
|
EEC19
|
17
|
B
|
100% R5
|
0.6
|
0.26
|
23
|
EEC36
|
21
|
B
|
100% R5
|
1.9
|
0.82
|
62
|
VC04
|
24
|
C
|
100% R5
|
4.8
|
1.00
|
100
|
VC05
|
14
|
B
|
100% R5
|
5.9
|
0.93
|
86
|
VC06a
|
24
|
B
|
100% R5
|
2.1
|
0.92
|
70
|
5
|
B
|
100% R5
|
0.02
|
–
|
60
|
VC14
|
12
|
F1
|
100% R5
|
4.4
|
0.99
|
96
|
VC15
|
14
|
B
|
100% R5
|
4.4
|
1.00
|
100
|
VC16
|
21
|
B
|
95% R5
|
5% X4
|
4.4
|
1.00
|
100
|
VC23
|
20
|
C
|
100% R5
|
2.5
|
1.00
|
100
|
VC31a
|
15
|
B
|
100% R5
|
6.4
|
0.98
|
93
|
VC32
|
17
|
B
|
100% R5
|
3.5
|
0.98
|
94
|
2
|
F1
|
100% R5
|
0.2
|
–
|
100
|
VC43
|
17
|
B
|
70% R5
|
30% X4
|
4.1
|
0.96
|
88
|
-
aHeterozygous patients for Δ32 CCR5 allele